Stocks TelegraphStocks Telegraph
Stock Ideas

CDNA Company Profile and Key Details

NASDAQ : CDNA

CareDx

$28.76
0.25+0.88%
At Close 4:00 PM
65.43
B-ESG ScoreESG Rating

Price Chart

Stock Price Today

CareDx, Inc (CDNA) stock surged +0.88%, trading at $28.76 on NASDAQ, up from the previous close of $28.51. The stock opened at $27.88, fluctuating between $27.88 and $28.81 in the recent session.

Stock Snapshot

28.51
Prev. Close
1.49B
Market Cap
27.875
Day Low
34.24
P/E Ratio
0.84
EPS (TTM)
-0.52
Cash Flow per Share
27.88
Open
51.66M
Number of Shares
28.81
Day High
97.36%
Free Float in %
4.89
Book Value
538.08K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Jul 13, 202627.9528.8027.6828.76560.96K
Jul 10, 202629.0529.2528.1128.51665.64K
Jul 09, 202627.7929.1527.7929.11699.77K
Jul 08, 202627.9228.6827.3227.551.64M
Jul 07, 202629.3629.4328.1928.31625.95K
Jul 06, 202629.1529.8828.9829.06723.62K
Jul 02, 202629.8230.0028.2829.19855.9K
Jul 01, 202628.7129.4628.6429.25726.72K
Jun 30, 202628.7829.4927.8728.50642.74K
Jun 29, 202628.7529.5828.7529.28497.98K
Jun 26, 202627.8529.0727.7628.821.65M
Jun 25, 202627.2428.4227.2427.851.32M
Jun 24, 202625.4127.2725.3927.131.37M
Jun 23, 202624.7025.6524.5025.12577.17K
Jun 22, 202626.2326.7824.9025.05733.87K
Jun 18, 202623.9326.2623.9326.182.74M
Jun 17, 202623.3124.0023.0023.48970.62K
Jun 16, 202624.0924.8523.0523.25938K
Jun 15, 202623.0224.1322.7324.08903.38K
Jun 12, 202623.5323.7722.7822.97769.01K

Contact Details

South San Francisco, CA 94080

United States

https://www.caredx.com415 287 2300

About Company

CareDx, Inc. is a global innovator specializing in the discovery, development, and commercialization of diagnostic and management tools designed for transplant recipients and their healthcare providers. The company's extensive portfolio features a range of specialized diagnostic solutions for organ monitoring, including: AlloSure Kidney, AlloSure Heart, and AlloSure Lung: Advanced tests employing donor-derived cell-free DNA (dd-cfDNA) technology to assess the health of kidney, heart, and lung transplants, respectively. AlloMap Heart: A gene expression-based solution specifically for heart transplant patients. AlloSeq cfDNA: A broader surveillance tool to measure dd-cfDNA levels in the blood. CareDx also provides cutting-edge human leukocyte antigen (HLA) typing technologies, such as TruSight HLA, an NGS-based high-resolution typing solution; Olerup SSP, which uses sequence-specific primer technology for HLA allele typing; QTYPE for precise HLA typing; and AlloSeq Tx, another high-resolution HLA typing offering. For stem cell transplant recipients, the company offers AlloSeq HCT for chimerism testing. Beyond diagnostics, CareDx develops vital software and digital platforms to streamline transplant patient management. These include Ottr, a dedicated transplant patient management software; XynQAPI, focused on transplant quality tracking and waitlist management; and AlloCare, a mobile application serving as a patient-centric resource for those who have undergone transplantation. The company distributes its products directly to clients, as well as through a network of third-party distributors and sub-distributors. CareDx has forged significant partnerships, including a licensing agreement with Illumina, Inc. for the distribution, development, and commercialization of next-generation sequencing (NGS) products and technologies. Additionally, it collaborates with Cibiltech SAS to commercialize iBox, a software designed for the predictive analysis of kidney allograft loss post-transplantation. Founded in 1998, the company was initially known as XDx, Inc. before rebranding to CareDx, Inc. in March 2014. Its headquarters are located in South San Francisco, California.

Company Information

Employees644
Beta2.43
Sales or Revenue$280.32M
5Y Sales Change%1.427%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Diagnostics & Research

Frequently Asked Questions

What is the current CareDx, Inc (CDNA) stock price?
CareDx, Inc (NASDAQ: CDNA) stock price is $28.76 in the last trading session. During the trading session, CDNA stock reached the peak price of $28.81 while $27.88 was the lowest point it dropped to. The percentage change in CDNA stock occurred in the recent session was 0.88% while the dollar amount for the price change in CDNA stock was $0.25.
CDNA's industry and sector of operation?
The NASDAQ listed CDNA is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. CareDx, Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of CDNA?
Dr. Mickey Y. Kim M.D.
Senior Vice President of Corporation Devel. & Head of Global Product
Mr. Jarrod Borkat
Senior Vice President and Head of Marketing & Portfolio Operations
Mr. Abraham Ronai Esq.
Chief Admin. & Legal Officer and Sec.
Mr. Alexander L. Johnson
Pres of Patient and Testing Services
Ms. Sasha King M.B.A.
Executive Officer
Dr. Reginald Seeto
Pres, Chief Executive Officer & Director
Dr. Peter Maag Ph.D.
Executive Director
Mr. Abhishek Jain
Chief Financial Officer & Principal Accounting Officer
Mr. Ian Cooney
Vice President of Investor Relations
Dr. Reginald Seeto M.D., MBBS
Pres, Chief Executive Officer & Director
Ms. Marica Grskovic Ph.D.
Chief Operating Officer
How CDNA did perform over past 52-week?
CDNA's closing price is 162.41% higher than its 52-week low of $10.96 where as its distance from 52-week high of $30.00 is -4.13%.
How many employees does CDNA have?
Number of CDNA employees currently stands at 644.
Link for CDNA official website?
Official Website of CDNA is: https://www.caredx.com
How do I contact CDNA?
CDNA could be contacted at phone 415 287 2300 and can also be accessed through its website. CDNA operates from 1 Tower Place, South San Francisco, CA 94080, United States.
How many shares of CDNA are traded daily?
CDNA stock volume for the day was 538.08K shares. The average number of CDNA shares traded daily for last 3 months was 846.66K.
What is the market cap of CDNA currently?
The market value of CDNA currently stands at $1.49B with its latest stock price at $28.76 and 51.66M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph